| Q34730950 | Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings |
| Q39437445 | Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau |
| Q35884346 | Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa |
| Q37470249 | Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau |
| Q36315149 | Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection |
| Q41761525 | Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene. |
| Q37452520 | Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression |
| Q35943789 | Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection |
| Q30406079 | Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique |
| Q37482051 | Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India |
| Q38995742 | Genetic characterization of HIV type 1 and type 2 from Bissau, Guinea-Bissau (West Africa). |
| Q36637244 | Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology |
| Q37341025 | HIV induced AIDS and related cancers: chronic immune activation and future therapeutic strategies |
| Q30352010 | HIV-1 Genetic Variability and Clinical Implications |
| Q44220773 | HIV-2 and T cell recognition |
| Q43050851 | HIV-2 capsids distinguish high and low virus load patients in a West African community cohort |
| Q33951633 | HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007. |
| Q35170089 | High level of HIV-1 drug resistance among patients with HIV-1 and HIV-1/2 dual infections in Guinea-Bissau |
| Q35883837 | Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. |
| Q93000948 | Immune Control of HIV |
| Q34046201 | Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa |
| Q39355550 | Longstanding presence of HIV-2 infection in Guinea-Bissau (West Africa). |
| Q34312423 | Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau. |
| Q39581028 | Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype |
| Q36419884 | Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau |
| Q36239954 | Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France |
| Q36282706 | Predicting the extinction of HIV-2 in rural Guinea-Bissau |
| Q28538242 | Profile of the HIV epidemic in Cape Verde: molecular epidemiology and drug resistance mutations among HIV-1 and HIV-2 infected patients from distinct islands of the archipelago |
| Q40334334 | Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2 |
| Q35970916 | Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection |
| Q24671064 | Tracing the origin and history of the HIV-2 epidemic |
| Q56782142 | Transmission of HIV-2 |
| Q37053015 | Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009. |
| Q33919925 | Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village |
| Q33267272 | Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau |